| 10/26 | Completion of Enrollment in Phase III Comparative Study for Investigational Regenerativ.. | PU |
| 10/26 | CHUGAI PHARMACEUTICAL : Script (including Q&A) | PU |
| 10/25 | CHUGAI PHARMACEUTICAL : Announces 2021 3rd Quarter Results | AQ |
| 10/25 | CHUGAI PHARMACEUTICAL : Notice of Revisions to Financial Forecasts | AQ |
| 10/25 | CHUGAI PHARMACEUTICAL : Notice of Revisions to Dividend Forecast for Fiscal Year Ending De.. | AQ |
| 10/25 | CHUGAI PHARMACEUTICAL : Construction of New Bio API Plant for Early Clinical Trials to Acc.. | AQ |
| 10/25 | CHUGAI PHARMACEUTICAL : announced Organizational Changes | AQ |
| 10/25 | CHUGAI PHARMACEUTICAL : Posts 26% Growth in Nine-Month Attributable Net Income, Raises FY2.. | MT |
| 10/25 | Nikkei 225 Slips 0.7% on Earnings, Election Outlooks | MT |
| 10/25 | Nikkei slips on soft earnings, U.S. tech worries | RE |
| 10/25 | PRESS RELEASE : Roche launches comprehensive genomic profiling kit to expand access to per.. | DJ |
| 10/24 | Nikkei drops on soft earnings, U.S. tech worries | RE |
| 10/22 | PRESS RELEASE : FDA approves Roche's Susvimo, a -2- | DJ |
| 10/22 | CHUGAI PHARMACEUTICAL : Organizational Changes | PU |
| 10/22 | CHUGAI PHARMACEUTICAL : Announces 2021 3rd Quarter Results | PU |
| 10/22 | CHUGAI PHARMACEUTICAL : Notice of Revisions to Financial Forecasts | PU |
| 10/22 | CHUGAI PHARMACEUTICAL : Notice of Revisions to Dividend Forecast for Fiscal Year Ending De.. | PU |
| 10/22 | CHUGAI PHARMACEUTICAL : Construction of New Bio API Plant for Early Clinical Trials to Acc.. | PU |
| 10/22 | CHUGAI PHARMACEUTICAL : 3Q Results (Jan-Sep 2021) | PU |
| 10/22 | CHUGAI PHARMACEUTICAL : Supplementary Materials | PU |
| 10/22 | CHUGAI PHARMACEUTICAL : CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited)(for the thi.. | PU |
| 10/22 | CHUGAI PHARMACEUTICAL : Supplementary Materials for Consolidated Financial Results for the.. | PU |
| 10/22 | Chugai Pharmaceutical Co., Ltd. Revises Consolidated Earnings Guidance for the Year End.. | CI |
| 10/21 | CHUGAI PHARMACEUTICAL : Contribution of Para-transit Vehicles to Welfare Services | AQ |
| 10/21 | ROCHE : Chugai Pharmaceutical Co., Ltd. - F. Hoffmann-La Roche Announces Third Quarter Sal.. | AQ |
| 10/20 | Chugai Pharmaceutical, Oncolys BioPharma to Nix Oncolytic Viral Immunotherapy License D.. | MT |
| 10/20 | CHUGAI PHARMACEUTICAL : Contribution of Para-transit Vehicles to Welfare Services | PU |
| 10/20 | CHUGAI PHARMACEUTICAL : F. Hoffmann-La Roche Announces Third Quarter Sales 2021 | PU |
| 10/19 | CHUGAI PHARMACEUTICAL : Atea Announces Update and Topline Results of MOONSONG Study Evalua.. | PU |
| 10/19 | CHUGAI PHARMACEUTICAL : Announces the Decision of the Termination of Exclusive License Agr.. | PU |
| 10/19 | Chugai Pharmaceutical Co., Ltd. Announces the Decision of the Termination of Exclusive .. | CI |
| 10/15 | PRESS RELEASE : US FDA approves Roche's Tecentriq -2- | DJ |
| 10/15 | PRESS RELEASE : Roche announces PathAI collaboration for artificial intelligence-based dig.. | DJ |
| 10/14 | CHUGAI PHARMACEUTICAL : New Four-year Data Show Sustained Relapse Reduction by Chugai's En.. | BU |
| 10/14 | Chugai Pharmaceutical Co., Ltd. Announces New Longer-Term Efficacy and Safety Data for .. | CI |
| 10/14 | PRESS RELEASE : New four-year data show Roche's -2- | DJ |
| 10/14 | PRESS RELEASE : Roche's Gazyvaro shorter 90-minute infusion time approved in Europe for pe.. | DJ |
| 10/13 | SYNAIRGEN : Appoints Chugai Pharma Executive as Chief Regulatory Officer | MT |
| 10/13 | PRESS RELEASE : Data up to 8-years for Roche's -2- | DJ |
| 10/11 | ROCHE : Japanese Unit Seeks Regulatory Nod For Additional COVID-19 Monoclonal Antibody Ind.. | MT |
| 10/11 | CHUGAI PHARMACEUTICAL : Files for Additional Indications of Antibody Cocktail Ronapreve fo.. | PU |
| 10/05 | PRESS RELEASE : Roche to present new data on -3- | DJ |
| 10/04 | CHUGAI PHARMACEUTICAL : Receives Orphan Drug Designation for Hemlibra in Acquired Hemophil.. | AQ |
| 10/01 | CHUGAI PHARMACEUTICAL : Receives Orphan Drug Designation for Hemlibra in Acquired Hemophil.. | PU |
| 09/30 | CHUGAI PHARMACEUTICAL : Roche Announces Results of REGN-COV 2066 Study for Ronapreve for t.. | PU |
| 09/30 | PRESS RELEASE : Phase II/III trial shows -2- | DJ |
| 09/29 | CHUGAI PHARMACEUTICAL : Script (including Q&A) | PU |
| 09/28 | CHUGAI PHARMACEUTICAL : Zenyaku Kogyo Co. and Chugai Pharmaceutical Co. - Anti-CD20 Monocl.. | AQ |
| 09/28 | CHUGAI PHARMACEUTICAL : Summary | PU |
| 09/27 | CHUGAI PHARMACEUTICAL : Anti-CD20 Monoclonal Antibody Rituxan Approved for Additional Indi.. | PU |
| 09/24 | PRESS RELEASE : Roche presents new data at World -2- | DJ |
| 09/22 | PRESS RELEASE : Roche launches three respiratory test panels on cobas 6800/8800 Systems in.. | DJ |
| 09/20 | PRESS RELEASE : New Phase III data support the -2- | DJ |
| 09/17 | PRESS RELEASE : Roche receives positive CHMP -2- | DJ |
| 09/15 | PRESS RELEASE : Roche opens access to pathology imaging tools to improve patient care | DJ |
| 09/14 | PRESS RELEASE : Temedica develops new digital companion Brisa for people with multiple scl.. | DJ |
| 09/13 | CHUGAI PHARMACEUTICAL : Script (including Q&A) | PU |
| 09/09 | PRESS RELEASE : Roche signs definitive share purchase agreement with long-term partner TIB.. | DJ |
| 09/08 | Nikkei 225 Up 0.9%, Tops 30,000, Extends Rally on New Government Hopes | MT |
| 09/08 | Japan's Nikkei ends at near 6-month high on bargain hunting for cheap stocks | RE |
| 09/07 | PRESS RELEASE : Roche to present data from -2- | DJ |
| 08/30 | Nikkei 225 Gains 0.5% on Wall Street Cues, Softer Yen | MT |
| 08/30 | CHUGAI PHARMACEUTICAL : Script (including Q&A) | PU |
| 08/27 | PRESS RELEASE : Roche provides update on Tecentriq -2- | DJ |
| 08/25 | CHUGAI PHARMACEUTICAL : Presentation | PU |
| 08/19 | Toyota drags Nikkei to 7-month low after output cut report | RE |
| 08/18 | Japanese shares fall, struggle to shake off Delta variant fears | RE |
| 08/18 | PRESS RELEASE : Roche receives FDA approval for first companion diagnostic to identify dMM.. | DJ |
| 08/18 | Nikkei snaps 4-day losing streak, but Delta worries persist | RE |
| 08/17 | Japanese shares bounce back as defensive stocks gain | RE |
| 08/12 | CHUGAI PHARMACEUTICAL : Launches Evrysdi Dry Syrup 60 mg for the Treatment of Spinal Muscu.. | PU |
| 08/12 | Toshiba CEO Hopes to Vote on New Board Chairman by Year-End | DJ |
| 08/03 | PRESS RELEASE : US FDA grants Priority Review to Roche's Tecentriq as adjuvant treatment f.. | DJ |
| 08/02 | CHUGAI PHARMACEUTICAL : Launches FoundationOne Liquid CDx Cancer Genomic Profile as the Fi.. | PU |
| 07/30 | CHUGAI PHARMACEUTICAL : Continues to be Listed for All ESG Indices Selected by GPIF | PU |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
